Author

D. J. Christensen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 5

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:drug response / drug discovery· 4 Organism:mouse· 3 Research Focus:phylogenetics / evolution· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

C. Moon· 5 shared R. O. Williams· 5 shared S. Sahakijpijarn· 4 shared J. J. Koleng· 3 shared H. Xu· 2 shared Z. Cui· 2 shared Z. N. Warnken· 2 shared A. Vitug· 1 shared

Activity by Year

2020-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersPharmacology & Toxicology

C. Moon

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Formulation of Dry Powders of Vaccines Containing MF59 or AddaVax by Thin-Film Freeze-Drying

K. AboulFotouh, N. Uno, H. Xu, C. Moon, S. Sahakijpijarn, D. J. Christensen, G. J. Davenport, C. Cano, T. M. Ross, R. O. Williams, Z. Cui

This study demonstrates that thin-film freeze-drying can convert MF59 or AddaVax-adjuvanted vaccines into dry powders while preserving immunogenicity and stability.

bioRxiv · Oct 21, 2021 · PreprintPharmacology & Toxicology

AUG-3387, a Human-Derived Monoclonal Antibody Neutralizes SARS-CoV-2 Variants and Reduces Viral Load from Therapeutic Treatment of Hamsters In Vivo

C. J. Emig, M. A. Mena, S. J. Henry, A. Vitug, C. J. Ventura, D. Fox, X. H. Nguyenla, H. Xu, C. Moon, S. Sahakijjpijarn, P. J. Kuehl, D. Revelli, Z. Cui, R. O. Williams, D. J. Christensen

AUG-3387, a human monoclonal antibody, neutralizes SARS-CoV-2 variants and reduces viral load in hamsters when administered as a dry powder inhaler formulation.

bioRxiv · Oct 12, 2021 · PreprintPharmacology & Toxicology

Niclosamide Inhalation Powder Made by Thin-Film Freezing: Pharmacokinetic and Toxicology Studies in Rats and Hamsters

M. O. Jara, Z. N. Warnken, S. Sahakijpijarn, C. Moon, E. Y. Maier, D. J. Christensen, J. J. Koleng, J. I. Peters, S. D. Hackman, R. O. Williams

This paper develops a niclosamide inhalation powder using thin-film freezing and tests its pharmacokinetics and toxicity in rats and hamsters for COVID-19 treatment.

bioRxiv · Jan 26, 2021 · PreprintPharmacology & Toxicology

In Vivo Pharmacokinetic Study of Remdesivir Dry Powder for Inhalation in Hamsters

s. sahakijpijarn, C. Moon, Z. N. Warnken, E. Maier, J. E. DeVore, D. J. Christensen, J. J. Koleng, R. O. Williams

This study evaluates the pharmacokinetics of remdesivir dry powder for inhalation in hamsters, showing higher drug levels and suggesting a twice-daily dosing regimen.

bioRxiv · Dec 22, 2020Pharmacology & Toxicology

Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing

S. Sahakijpijarn, C. Moon, J. J. Koleng, D. J. Christensen, R. O. Williams

This paper develops a dry powder formulation of remdesivir for inhalation using thin film freezing, showing improved aerosol performance and lung delivery.

bioRxiv · Jul 26, 2020Pharmacology & Toxicology